Top Read Articles

    Published in last 1 year |  In last 2 years |  In last 3 years |  All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Journal of Surgery Concepts & Practice    2012, 17 (01): 17-20.   DOI: 10.16139/j.1007-9610.a2792
    Abstract4919)            Save
    Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2005, 10 (06): 539-541.   DOI: 10.16139/j.1007-9610.a1518
    Abstract3974)            Save
    Related Articles | Metrics | Comments0
    Interpretation of the 5th edition WHO classificaion and staging of tumors of digestive system: gastric tumors
    YU Yingyan, ZHU Zhenggang
    Journal of Surgery Concepts & Practice    2020, 25 (03): 207-210.   DOI: 10.16139/j.1007-9610.2020.03.007
    Abstract2368)   HTML112)    PDF(pc) (439KB)(1379)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2009, 14 (01): 46-48.   DOI: 10.16139/j.1007-9610.a2173
    Abstract2185)            Save
    Related Articles | Metrics | Comments0
    Interpretation of the 5th edition WHO classification and staging of digestive system tumors: colorectal tumors
    YU Yingyan
    Journal of Surgery Concepts & Practice    2021, 26 (04): 312-317.   DOI: 10.16139/j.1007-9610.2021.04.008
    Abstract1993)   HTML87)    PDF(pc) (589KB)(1582)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Interpretation of the 2022 edition of “guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China”
    XU Bojin, PENG Wenfang, HUANG Shan
    Journal of Surgery Concepts & Practice    2023, 28 (06): 512-519.   DOI: 10.16139/j.1007-9610.2023.06.05
    Abstract1794)   HTML19)    PDF(pc) (889KB)(5505)       Save

    “Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China” (2022) (referred to as the “guidelines”) was officially published in August 2022 in the Chinese Journal of Endocrine Metabolism. These guidelines have been extensively updated from the 2007 version, with 15 sections covering the etiology, clinical manifestations, diagnosis, evaluation, and treatment of hyperthyroidism, as well as the management of specific types of thyrotoxicosis. The new version guidelines proposed 107 recommended opinions supported by stronger evidence, offering comprehensive and reliable guidance for clinical doctors and medical professionals dealing with thyrotoxicosis. This article aimed to extract the key points and recommended strategies from the guidelines to help clinical doctors better understand and apply the latest guiding principles.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Chinese interpretation of Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) and Ruijin clinical practice
    YAN Chao, LU Sheng, YAN Min, ZHU Zhenggang
    Journal of Surgery Concepts & Practice    2023, 28 (04): 326-354.   DOI: 10.16139/j.1007-9610.2023.04.010
    Abstract1718)   HTML37)    PDF(pc) (4954KB)(6905)       Save

    “Japanese Gastric Cancer Treatment Guidelines” have been important guidelines for the treatment of gastric cancer in Japan and worldwide. The English version “Japanese Gastric Cancer Treatment Guidelines 2021 (6th Edition)” published in January 2023 consists of two parts. The first part includes diagnostic and treatment methods, such as surgery, endoscopic resection, chemotherapy, follow-up. The second part addresses clinical issues, including recommendations and explanations for clinical hot topics. This article will provide a Chinese interpretation of the guidelines and briefly introduce our hospital's clinical practice in the diagnosis and treatment of gastric cancer.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Breast cancer patients with 1-2 positive sentinel lymph nodes without axillary lymph node dissection: influencing factors and prognosis
    CHEN Xiaosong, WU Jiayi, HUANG Ou, HE Jianrong, ZHU Li, LI Yafen, CHEN Weiguo, SHEN Kunwei
    Journal of Surgery Concepts & Practice    2019, 24 (05): 428-433.   DOI: 10.16139/j.1007-9610.2019.05.012
    Abstract1619)      PDF(pc) (533KB)(119)       Save
    Objective To analyze the factors influencing breast cancer patients with 1-2 positive sentinel lymph nodes which meets ACOSGO Z0011 criteria without further axillary lymph node dissection (ALND) and their prognosis. Methods Patients with cT1-2N0 invasive breast cancer received breast conserving surgery and radiotherapy were enrolled retrospectively in Comprehensive Breast Health Center, Rujin Hospital between January 2012 and August 2019. Factors which influenced not to receive further ALND in patients with 1-2 positive sentinel lymph node and its association with prognosis were analyzed. Results were listed as odds ratio and 95% confidence interval. Results A total of 161 patients were studied, including 78 patients without ALND in the SLNB group and 83 patients in the ALND group. There were 11 (13.3%) patients with non-SLN metastasis and 4 (4.8%) patients with 3 axillary lymph node (ALN) metastasis in the ALND group. Both univariate and multivariate analysis found that surgical-year was associated with ALND (P<0.001). Patients in more recent surgical-year were received less ALND. Eleven (14.1%) and 6 (3.6%) patients in the SLNB and ALND groups had no further adjuvant chemotherapy, respectively. Univariate analysis showed that age (P<0.001), menopausal status (P=0.016), and ALN surgery(P=0.018) were related with adjuvant chemotherapy. Multivariate analysis showed that only age was independently related with chemotherapy(P<0.001). With a median follow up of 42.0 months, ALN recurrence was found only 1 (1.3%) patient in the SLNB group and none in the ALND group. Conclusions Patients with 1-2 positive sentinel nodes who met the eligible criteria of ACOSOG Z0011 trial could be treated without ALND. The association of ALND with long-term survival deserves further evaluation.
    Reference | Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2018, 23 (03): 221-226.   DOI: 10.16139/j.1007-9610.2018.03.009
    Abstract1343)      PDF(pc) (869KB)(1144)       Save
    Reference | Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2011, 16 (03): 252-255.   DOI: 10.16139/j.1007-9610.a2687
    Abstract1335)            Save
    Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2019, 24 (06): 550-554.   DOI: 10.16139/j.1007-9610.2019.06.017
    Abstract1333)      PDF(pc) (676KB)(415)       Save
    Reference | Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    1998, 3 (03): 90-5.   DOI: 10.16139/j.1007-9610.a0090
    Abstract1330)            Save
    Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2017, 22 (05): 411-416.   DOI: 10.16139/j.1007-9610.a3607
    Abstract1326)            Save
    Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2014, 19 (02): 131-135.   DOI: 10.16139/j.1007-9610.a3124
    Abstract1310)            Save
    Related Articles | Metrics | Comments0
    Progress of study on gallbladder adenomyomatosis: pathogenesis, diagnosis and treatment
    CHEN Xuanwu, YANG Chuanyu, JIANG Minjie, DU Weidong
    Journal of Surgery Concepts & Practice    2022, 27 (01): 87-90.   DOI: 10.16139/j.1007-9610.2022.01.020
    Abstract1296)   HTML51)    PDF(pc) (407KB)(604)       Save

    Gallbladder adenomyomatosis(GA) is a relatively rare benign disease of unknown both etiology and pathogenesis. The development of imaging technology improved diagnosis of GA. Some believed that GA related to gallbladder cancer, which is still controversial. Preventive cholecystectomy was proposed to treat GA and some GA could be followed up. Therefore no consensus of treatment of GA is present now. Etiology, pathogenesis, diagnosis and treatment of GA were included in this article.

    Reference | Related Articles | Metrics | Comments0
    The fifth edition of WHO classification of digestive system tumors: update and progress on biliary system tumors
    LUO Fangxiu, MA Qianchen, YUAN Fei
    Journal of Surgery Concepts & Practice    2023, 28 (02): 124-131.   DOI: 10.16139/j.1007-9610.2023.02.08
    Abstract1292)   HTML26)    PDF(pc) (3365KB)(4377)       Save

    Overall, there was little change in biliary system tumors of the 5th edition of WHO classification of digestive system tumors after update. The three-tiered classification of biliary intraepithelial neoplasia changed to two-tiered system: high-grade and low-grade, in the section of benign tumors and precancerous lesions. And both intracholecystic and intraductal papillary tumors associated with invasive carcinoma were added. The classification of intrahepatic bile duct tumors introduced parts of bile duct adenoma and bile duct adenofibroma, which were mentioned previously in the differential diagnosis with bile duct carcinoma. Intrahepatic cholangiocarcinoma was divided into small bile duct subtype and large bile duct subtype in the 5th edition of WHO classification, and the names of cholangiocellular carcinoma and cholangiole cell carcinoma were no longer recommended to use. Extrahepatic cholangiocarcinoma was listed as a separate part for the first time, including squamous cell carcinoma, adenosquamous carcinoma and undifferentiated carcinoma in addition to common histological types. Some new contents of molecular pathology in the 5th edition of WHO classification were added, which provided the basis for precise classification and diagnosis of tumors in biliary system.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Journal of Surgery Concepts & Practice    2017, 22 (03): 240-247.   DOI: 10.16139/j.1007-9610.a3545
    Abstract1288)            Save
    Related Articles | Metrics | Comments0
    Development and prospects of ERCP in China
    LI Wen
    Journal of Surgery Concepts & Practice    2023, 28 (04): 279-282.   DOI: 10.16139/j.1007-9610.2023.04.001
    Abstract1268)   HTML19)    PDF(pc) (838KB)(2375)       Save

    Endoscopic retrograde cholangio-pancreatography (ERCP) is an interventional endoscopic technique aimed at the diagnoses and treatment of biliary and pancreatic diseases under the guidance of endoscopy and X-ray ima-ging. ERCP was introduced into China from the 1970s. In the 1990s, ERCP was gradually popularized and applied in China with the development of medical technique and improvement of equipment, more medical institutions started to carry out ERCP. After 2000, ERCP technology and equipment were further upgraded and improved in China. Many secondary and tertiary hospitals began to establish the ERCP centers. Meanwhile, workshops and training also facilitated the teaching and practice of ERCP and cultivated more professionals of ERCP. In recent years, the technical level of ERCP in China has been continuously improved, and technologies and equipments are constantly updated and iterated. Currently, ERCP has become one of important techniques in the endoscopic field, playing an important role in the diagnosis and treatment of biliary and pancreatic diseases. The vigorous development of ERCP in China is attributed to the advancement of medical science, the improvement of technology and the efforts of generations of ERCP specialists.

    Reference | Related Articles | Metrics | Comments0
    Conversion therapy for far-advanced gastric cancer with paclitaxel hyperthermia intraperitoneal and intravenous chemotherapy: a case report
    JIANG Songyao, ZHAO Liangchao, YAN Xiaowei, HU Jiele, XIANG Ming
    Journal of Surgery Concepts & Practice    2020, 25 (02): 152-154.   DOI: 10.16139/j.1007-9610.2020.02.013
    Abstract1241)   HTML5)    PDF(pc) (545KB)(178)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Retrospective study on Bethesda Ⅴ thyroid nodule in diagnosis of papillary thyroid carcinoma: retrospective study
    YAN Shouyi, CHEN Hongbin, ZHANG Liyong, WANG Bo, CAI Shaojun, LIN Siying, ZHAO Wenxin
    Journal of Surgery Concepts & Practice    2021, 26 (06): 512-516.   DOI: 10.16139/j.1007-9610.2021.06.011
    Abstract1229)   HTML8)    PDF(pc) (542KB)(525)       Save
    Objective To study on preoperative diagnosis of papillary thyroid carcinoma (PTC) with Bethesda Ⅴ thyroid nodules retrospectively and to explore the differences of clinical parameters between Bethesda Ⅴ and Ⅵ thyroid nodules. Methods The clinical data of 430 patients were analyzed. Results Univariate analysis showed that there were significant differences of Bethesda Ⅴ nodules in nodule boundary, tumor size and echo between PTC group of 159 cases and benign group of 20 cases (P<0.05). It was shown from multivariate analysis that nodule boundary, tumor size and echo were risk factors for malignant diagnosis of BethesdaⅤnodule. The differences were present significantly in TI-RADS grade, aspect ratio and echo between Bethesda ⅤPTC group of 159 case and Bethesda Ⅵ thyroid nodule group of 251 cases (P<0.05). Further multivariate analysis showed that TI-RADS grade, aspect ratio, relation of nodule with capsule, thyroid peroxidase antibody level and echo were the risk factors for the diagnosis of PTC. Conclusions Bethesda Ⅴ nodules with higher grade of TI-RADS are malignant more possibly and those with lower grade of TI-RADS need to be evaluated such as thyroid nodules sizes, relation of nodules with capsule and thyroid peroxidase antibody level.
    Table and Figures | Reference | Related Articles | Metrics | Comments0